Suchergebnisse - "Wang, Han-Lei"

PubPharm (10)

1

Efficacy and safety of adjuvant therapy with PD‑1/PD‑L1 inhibitors in cancer

enthalten in: Experimental and therapeutic medicine | 2022

von Mo, D. | Liang, Z. | Chen, L. | +3

2

Kochiae Fructus : Evaluation on the antioxidant properties and oral safety of its water decoction

enthalten in: Toxicon : official journal of the International Society on Toxinology | 2022

von Chen, X. | Li, B. | Zhao, X. | +5

3

Efficacy of immune checkpoint inhibitor as maintenance therapy for advanced or metastatic cancers : A meta-analysis of randomized controlled trials

enthalten in: Medicine | 2022

von Mo, D. | Huang, J. | Luo, P. | +2

4

The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer : a meta-analysis

enthalten in: Investigational new drugs | 2022

von Meng, L. | Huang, J. | Luo, P. | +2

5

PD-1/PD-L1 inhibitor plus chemotherapy versus standard of care in the first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma

enthalten in: European archives of oto-rhino-laryngology and head & neck | 2022

von Mo, D. | Huang, J. | Luo, P. | +3

6

PD-1/PD-L1 inhibitor plus chemotherapy versus standard of care in the first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma

enthalten in: European archives of oto-rhino-laryngology and head & neck | 2022

von Mo, D. | Huang, J. | Luo, P. | +3

7

Antidiabetic potential of Catechu via assays for α-glucosidase, α-amylase, and glucose uptake in adipocytes

enthalten in: Journal of ethnopharmacology | 2022

von Zhang, K. | Chen, X. | Zhao, X. | +4

8

The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis

enthalten in: Investigational new drugs | 2022

von Meng, L. | Huang, J. | Luo, P. | +2

9

The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis

enthalten in: Investigational new drugs | 2022

von Meng, L. | Huang, J. | Luo, P. | +2

10

The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis

enthalten in: Investigational new drugs | 2022

von Meng, L. | Huang, J. | Luo, P. | +2

1
[1]